Scott Hirsch is the founder of Firefly Bio. Firefly Bio has raised $94M in total funding. Latest round: Series A. Based in South San Francisco, USA.
Scott Hirsch is the CEO of Firefly Bio, a biotechnology company based in South San Francisco, CA. The company develops novel degrader antibody conjugates (DACs) to treat cancer, combining antibody-drug conjugates with selective protein degraders. Firefly Bio emerged from stealth mode in February 2024 with a $94 million Series A financing.
Full founder directory · Investor directory · Company funding database · Fundraising library